MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
Arshad M. Khanani, David M. Brown, Glenn J. Jaffe, Charles C. Wykoff, Eser Adiguzel, Randall Wong, Xiangyi Meng, Jeffrey S. Heier
Topics & Concepts
AfliberceptMedicineMacular degenerationOphthalmologyVisual acuityRandomized controlled trialRetinalChoroidal neovascularizationClinical endpointSurgeryBevacizumabChemotherapyRetinal Diseases and TreatmentsOphthalmology and Visual Impairment StudiesOcular Diseases and Behçet’s Syndrome